BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 17110062)

  • 1. Lactose: a definitive guide to polymorph determination.
    Kirk JH; Dann SE; Blatchford CG
    Int J Pharm; 2007 Apr; 334(1-2):103-14. PubMed ID: 17110062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystalline polymorphism and molecular structure of sodium pravastatin.
    Martín-Islan AP; Cruzado MC; Asensio R; Sainz-Díaz CI
    J Phys Chem B; 2006 Dec; 110(51):26148-59. PubMed ID: 17181270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of weak interactions in developing 1,3-bis(4,6-dimethyl-1H-nicotinonitrile-1-yl)1,3-dioxy propane polymorphs.
    Tewari AK; Singh VP; Dubey R; Puerta C; Valerga P; Verma R
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1267-75. PubMed ID: 21664173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of amorphous content in the pharmaceutical process environment.
    Savolainen M; Jouppila K; Pajamo O; Christiansen L; Strachan C; Karjalainen M; Rantanen J
    J Pharm Pharmacol; 2007 Feb; 59(2):161-70. PubMed ID: 17270070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy.
    Skorda D; Kontoyannis CG
    Talanta; 2008 Jan; 74(4):1066-70. PubMed ID: 18371751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative determination of polymorphic impurity by X-ray powder diffractometry in an OROS formulation.
    Varasteh M; Deng Z; Hwang H; Kim YJ; Wong GB
    Int J Pharm; 2009 Jan; 366(1-2):74-81. PubMed ID: 18840515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the relative amounts of three crystal forms of a benzimidazole drug in complex finished formulations by FT-Raman spectroscopy.
    De Spiegeleer B; Seghers D; Wieme R; Schaubroeck J; Verpoort F; Slegers G; Van Vooren L
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):275-80. PubMed ID: 16085143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy.
    Virtanen T; Maunu SL
    Int J Pharm; 2010 Jul; 394(1-2):18-25. PubMed ID: 20416365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellulose of Salicornia brachiata.
    Sanandiya ND; Prasad K; Meena R; Siddhanta AK
    Nat Prod Commun; 2010 Apr; 5(4):603-6. PubMed ID: 20433080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative determination of famotidine polymorphs: X-ray powder diffractometric and Raman spectrometric study.
    Német Z; Kis GC; Pokol G; Demeter A
    J Pharm Biomed Anal; 2009 Feb; 49(2):338-46. PubMed ID: 19131203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product.
    Pöllänen K; Häkkinen A; Reinikainen SP; Rantanen J; Karjalainen M; Louhi-Kultanen M; Nyström L
    J Pharm Biomed Anal; 2005 Jun; 38(2):275-84. PubMed ID: 15925219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and characterization of organic nonlinear optical crystal of 1-chloro-2,4-dinitrobenzene (CDNB).
    Sethuraman K; Ramesh Babu R; Vijayan N; Gopalakrishnan R; Ramasamy P
    Spectrochim Acta A Mol Biomol Spectrosc; 2007 Mar; 66(3):707-11. PubMed ID: 16875866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
    Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
    Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
    Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
    Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FT-Raman, FT-IR spectroscopy and PIXE analysis applied to gallstones specimens.
    Paluszkiewicz C; Kwiatek WM; Gałka M; Sobieraj D; Wentrup-Byrne E
    Cell Mol Biol (Noisy-le-grand); 1998 Feb; 44(1):65-73. PubMed ID: 9551638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced calibration strategy for in situ quantitative monitoring of phase transition processes in suspensions using FT-Raman spectroscopy.
    Chen ZP; Fevotte G; Caillet A; Littlejohn D; Morris J
    Anal Chem; 2008 Sep; 80(17):6658-65. PubMed ID: 18665607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphism of cellulose I family: reinvestigation of cellulose IVI.
    Wada M; Heux L; Sugiyama J
    Biomacromolecules; 2004; 5(4):1385-91. PubMed ID: 15244455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism of Irganox 1076: Discovery of new forms and direct characterization of the polymorphs on a medical device by Raman microspectroscopy.
    Saunier J; Mazel V; Paris C; Yagoubi N
    Eur J Pharm Biopharm; 2010 Aug; 75(3):443-50. PubMed ID: 20433921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and physicochemical characterization of caffeine-citric acid co-crystal polymorphs.
    Mukaida M; Watanabe Y; Sugano K; Terada K
    Eur J Pharm Sci; 2015 Nov; 79():61-6. PubMed ID: 26360836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation mechanism of a new carbamazepine/malonic acid cocrystal polymorph.
    Limwikrant W; Nagai A; Hagiwara Y; Higashi K; Yamamoto K; Moribe K
    Int J Pharm; 2012 Jul; 431(1-2):237-40. PubMed ID: 22537807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.